These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 34244734)

  • 21. Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials.
    Dicembrini I; Cosentino C; Monami M; Mannucci E; Pala L
    Acta Diabetol; 2021 Apr; 58(4):401-410. PubMed ID: 32789691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparing the effectiveness of continuous subcutaneous insulin infusion with multiple daily insulin injection for patients with type 1 diabetes mellitus evaluated by retrospective continuous glucose monitoring: A real-world data analysis.
    Keyu G; Jiaqi L; Liyin Z; Jianan Y; Li F; Zhiyi D; Qin Z; Xia L; Lin Y; Zhiguang Z
    Front Public Health; 2022; 10():990281. PubMed ID: 36091534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes.
    Vigersky RA; McMahon C
    Diabetes Technol Ther; 2019 Feb; 21(2):81-85. PubMed ID: 30575414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of professional continuous glucose monitoring as an adjuvant educational tool for improving glycemic control in patients with type 2 diabetes.
    Rivera-Ávila DA; Esquivel-Lu AI; Salazar-Lozano CR; Jones K; Doubova SV
    BMC Endocr Disord; 2021 Apr; 21(1):79. PubMed ID: 33888117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycaemia in low-premixed insulin analogue type 2 diabetes patients in a real-world setting: are the CGM targets met?
    Krajnc M; Kravos Tramšek NA
    Eur J Med Res; 2023 Mar; 28(1):111. PubMed ID: 36882852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel Biochemical Markers of Glycemia to Predict Pregnancy Outcomes in Women With Type 1 Diabetes.
    Meek CL; Tundidor D; Feig DS; Yamamoto JM; Scott EM; Ma DD; Halperin JA; Murphy HR; Corcoy R;
    Diabetes Care; 2021 Mar; 44(3):681-689. PubMed ID: 33495292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Relationships Between Time in Range, Hyperglycemia Metrics, and HbA1c.
    Beck RW; Bergenstal RM; Cheng P; Kollman C; Carlson AL; Johnson ML; Rodbard D
    J Diabetes Sci Technol; 2019 Jul; 13(4):614-626. PubMed ID: 30636519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship Between Time-in-Range, HbA1c, and the Glucose Management Indicator in Pregnancies Complicated by Type 1 Diabetes.
    Shah VN; Snell-Bergeon JK; Demmitt JK; Joshee P; Garcetti R; Pyle L; Polsky S
    Diabetes Technol Ther; 2021 Dec; 23(12):783-790. PubMed ID: 34524020
    [No Abstract]   [Full Text] [Related]  

  • 29. The Relationship Between Glycated Hemoglobin and Time in Range in a Pediatric Population.
    Vandenbempt M; Matheussen H; Charleer S; Rochtus A; Casteels K
    Diabetes Technol Ther; 2024 May; 26(5):346-350. PubMed ID: 38133644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glycemic control assessed by continuous glucose monitoring during pregnancy in women with type 1 diabetes and its association with preeclampsia, an observational Swedish cohort study.
    Englund Ögge L; Dotevall A; Elfvin A; Sandgren U; Linden K; Bohlin L; Wallstersson B; Sjödell M; Augustinsson J; Hagman A
    Acta Obstet Gynecol Scand; 2024 Jul; 103(7):1426-1436. PubMed ID: 38725185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): A multicentre randomized controlled trial.
    Voormolen DN; DeVries JH; Sanson RME; Heringa MP; de Valk HW; Kok M; van Loon AJ; Hoogenberg K; Bekedam DJ; Brouwer TCB; Porath M; Erdtsieck RJ; NijBijvank B; Kip H; van der Heijden OWH; Elving LD; Hermsen BB; Potter van Loon BJ; Rijnders RJP; Jansen HJ; Langenveld J; Akerboom BMC; Kiewiet RM; Naaktgeboren CA; Mol BWJ; Franx A; Evers IM
    Diabetes Obes Metab; 2018 Aug; 20(8):1894-1902. PubMed ID: 29603547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of real-time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial.
    Secher AL; Ringholm L; Andersen HU; Damm P; Mathiesen ER
    Diabetes Care; 2013 Jul; 36(7):1877-83. PubMed ID: 23349548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuous Glucose Monitoring Metrics for Pregnancies Complicated by Diabetes: Critical Appraisal of Current Evidence.
    Szmuilowicz ED; Barbour L; Brown FM; Durnwald C; Feig DS; O'Malley G; Polsky S; Aleppo G
    J Diabetes Sci Technol; 2024 Jul; 18(4):819-834. PubMed ID: 38606830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous glucose monitor use with and without remote monitoring in pregnant women with type 1 diabetes: A pilot study.
    Polsky S; Garcetti R; Pyle L; Joshee P; Demmitt JK; Snell-Bergeon JK
    PLoS One; 2020; 15(4):e0230476. PubMed ID: 32298269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is there a difference in pregnancy and glycemic outcome in patients with type 1 diabetes on insulin pump with constant or intermittent glucose monitoring? A pilot study.
    Petrovski G; Dimitrovski C; Bogoev M; Milenkovic T; Ahmeti I; Bitovska I
    Diabetes Technol Ther; 2011 Nov; 13(11):1109-13. PubMed ID: 21751889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Techniques of monitoring blood glucose during pregnancy for women with pre-existing diabetes.
    Moy FM; Ray A; Buckley BS
    Cochrane Database Syst Rev; 2014 Apr; (4):CD009613. PubMed ID: 24782359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationships between HbA1c and continuous glucose monitoring metrics of glycaemic control and glucose variability in a large cohort of children and adolescents with type 1 diabetes.
    Piona C; Marigliano M; Mozzillo E; Rosanio F; Zanfardino A; Iafusco D; Maltoni G; Zucchini S; Piccinno E; Delvecchio M; Maffeis C
    Diabetes Res Clin Pract; 2021 Jul; 177():108933. PubMed ID: 34216681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin pump therapy with and without continuous glucose monitoring in pregnant women with type 1 diabetes: a prospective observational Orchestra Foundation study in Poland.
    Cypryk K; Wender-Ozegowska E; Cyganek K; Sieradzki J; Skoczylas K; Chen X; Cordero TL; Shin J; Cohen O
    Acta Diabetol; 2023 Apr; 60(4):553-561. PubMed ID: 36653533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of Factory-Calibrated Real-time Continuous Glucose Monitoring Improves Time in Target and HbA
    Thabit H; Prabhu JN; Mubita W; Fullwood C; Azmi S; Urwin A; Doughty I; Leelarathna L
    Diabetes Care; 2020 Oct; 43(10):2537-2543. PubMed ID: 32723843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical use of continuous glucose monitoring system in gestational diabetes mellitus and type 2 diabetes complicated with pregnancy].
    Song Y; Yang H
    Zhonghua Fu Chan Ke Za Zhi; 2014 Aug; 49(8):579-83. PubMed ID: 25354857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.